A promising drug for treating a debilitating genetic cartilage disorder is about to enter clinical trials in Australia. While preclinical results to date have been encouraging, exactly how the drug works remains a mystery.
Professor John Bateman from Murdoch Children’s Research Institute in Melbourne aims to solve it. Running in parallel with the clinical trial led by Professor Ravi Savarirayan, his research will use stem cells to understand what’s happening at a molecular level.
About 100 babies are born in Australia each year with genetic cartilage and bone disorders, which prevent the normal development and function of the skeleton.
With your support, the National Stem Cell Foundation of Australia wants to help fund John’s stem cell research into drugs to treat these painful genetic bone and cartilage diseases.
The Foundation aims to provide $100,000 for the project, by matching, dollar for dollar, every public donation of $500 or more, capped at $50,000.
If you would like your donation to be targeted specifically to this initiative, please use the online payment function in this section and, when prompted, specify ‘cartilage’ as the specific project you would like your donation allocated to. We will then match the amount you've donated and send the total amount to Mike at Queensland University of Technology.
Showing 1 reaction